Precision medicine utilizes nanocarriers to deliver therapeutic agents directly to targeted areas in the body, but current analysis methods often overlook the unique behaviors of individual particles by relying on average measurements from large populations.
For a professional tracking scientific breakthroughs, the key insight here is the need for advancements in techniques that can analyze individual nanoparticle behavior, rather than relying on average measurements. This could lead to significant improvements in the precision and effectiveness of nanocarrier-based therapies in precision medicine, making it a promising area for further research and potential breakthroughs.